OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study
Yuji Tohda, Yoichi Nakamura, Takao Fujisawa, et al.
Allergology International (2022) Vol. 72, Iss. 1, pp. 89-99
Open Access | Times Cited: 6
Yuji Tohda, Yoichi Nakamura, Takao Fujisawa, et al.
Allergology International (2022) Vol. 72, Iss. 1, pp. 89-99
Open Access | Times Cited: 6
Showing 6 citing articles:
A case of recurrent chronic eosinophilic pneumonia after switching from benralizumab to dupilumab
Daiki Nakashima, Eri Mori, Nobuyoshi Otori
Respiratory Medicine Case Reports (2024) Vol. 47, pp. 101968-101968
Open Access | Times Cited: 4
Daiki Nakashima, Eri Mori, Nobuyoshi Otori
Respiratory Medicine Case Reports (2024) Vol. 47, pp. 101968-101968
Open Access | Times Cited: 4
Dupilumab Efficacy and Safety in Patients With Persistent Asthma: Asia–Pacific Region
Qingling Zhang, Nanshan Zhong, Sahajal Dhooria, et al.
Clinical & Experimental Allergy (2025)
Open Access
Qingling Zhang, Nanshan Zhong, Sahajal Dhooria, et al.
Clinical & Experimental Allergy (2025)
Open Access
How to Understand Personalized Medicine in Atopic Dermatitis Nowadays?
Alicja Mesjasz, Karol Kołkowski, Andreas Wollenberg, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7557-7557
Open Access | Times Cited: 4
Alicja Mesjasz, Karol Kołkowski, Andreas Wollenberg, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7557-7557
Open Access | Times Cited: 4
Long-term Safety and Efficacy of Dupilumab in Patients With Uncontrolled, Moderate-to-Severe Asthma Recruited From Korean Centers: A Subgroup Analysis of the Phase 3 LIBERTY ASTHMA TRAVERSE Trial
Chin Kook Rhee, Jung‐Won Park, Heung‐Woo Park, et al.
Allergy Asthma and Immunology Research (2024) Vol. 16, Iss. 4, pp. 372-372
Open Access
Chin Kook Rhee, Jung‐Won Park, Heung‐Woo Park, et al.
Allergy Asthma and Immunology Research (2024) Vol. 16, Iss. 4, pp. 372-372
Open Access
The assessment of dupilumab in children with moderate-to-severe asthma and comorbid type 2 inflammatory diseases
Tingting Shi, S.Y. Wu, Rongshan Chen, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access
Tingting Shi, S.Y. Wu, Rongshan Chen, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access
Allergic Bronchopulmonary Aspergillosis and Asthma
Ritesh Agarwal, Valliappan Muthu, Inderpaul Singh Sehgal
(2024), pp. 227-256
Closed Access
Ritesh Agarwal, Valliappan Muthu, Inderpaul Singh Sehgal
(2024), pp. 227-256
Closed Access
